Cite
HARVARD Citation
Romero Prada, M. et al. (2018). Cost-effectiveness analysis of the human recombinant epidermal growth factor in the management of patients with diabetic foot ulcers. Diabetic foot & ankle. 9 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Romero Prada, M. et al. (2018). Cost-effectiveness analysis of the human recombinant epidermal growth factor in the management of patients with diabetic foot ulcers. Diabetic foot & ankle. 9 (1), p. . [Online].